 |
 |

Critical Illness Myopathy, Steroids, and Cytochrome P450
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Critical illness myopathy is a poorly understood, but increasingly recognized clinical syndrome that characteristically occurs in the intensive care unit among patients who have been treated with multiple drugs (particularly neuromuscular-blocking agents and antibiotics) and high-dose steroids.1-6 This rapidly progressive myopathy is characterized by muscle fiber atrophy and/or necrosis, often selectively affecting type 2 myofibers (Figure 1). Steroids are potent inducers of some forms of cytochrome P450.7 Recent studies8 suggest that cytochrome P450 is associated with skeletal muscle sarcoplasmic reticulum. Induction of cytochrome P450 and the consequent formation of reactive intermediates in the metabolism of some compounds result in the activation of calcium-release channels.9 Critical illness myopathy may result from steroid induction of cytochrome P450 associated with sarcoplasmic reticulum. The consequent production of reactive intermediate metabolites of other drugs given in the setting of critical illness then causes pathologic activation of calcium-release channels in sarcoplasmic reticulum and consequent . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Myopathic Changes Associated With Severe Acute Respiratory Syndrome: A Postmortem Case Series
Leung et al.
Arch Neurol 2005;62:1113-1117.
ABSTRACT
| FULL TEXT
|